Discrepancy in guidelines for the prevention of thrombo-embolism in patients with prosthetic heart valves.
作者信息
Stefanidis Alexandros, Skafidas Dimitrios, Papasteriadis Evaggelos
出版信息
Eur Heart J. 2007 Oct;28(20):2552-3; author reply 2553-4. doi: 10.1093/eurheartj/ehm353. Epub 2007 Sep 6.
PMID:17823214
Abstract
摘要
相似文献
1
Discrepancy in guidelines for the prevention of thrombo-embolism in patients with prosthetic heart valves.
Eur Heart J. 2007 Oct;28(20):2552-3; author reply 2553-4. doi: 10.1093/eurheartj/ehm353. Epub 2007 Sep 6.
2
Preventing thromboembolism in patients with prosthetic heart valves.
Cardiol Clin. 1994 Aug;12(3):487-93.
3
An overview of anticoagulants, antiplatelet agents, and the combination in patients with mechanical heart valves.
J Heart Valve Dis. 2004 May;13(3):319-24.
4
5
Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
Eur J Cardiothorac Surg. 2007 Apr;31(4):573-7. doi: 10.1016/j.ejcts.2007.02.002. Epub 2007 Feb 21.
6
Incidence of anticoagulation in patients with bioprostheses.
J Heart Valve Dis. 2004 May;13 Suppl 1:S88-9.
7
The efficacy and safety of combination warfarin and ASA therapy: a systematic review of the literature and update of guidelines.
Can J Cardiol. 1998 May;14(5):717-26.
8
Proceedings: Arterial thromboembolism and prosthetic heart valves. Effects of acetylsalicylic acid.
Thromb Diath Haemorrh. 1975 Nov 15;34(2):587-8.
9
[Anticoagulant and platelet-inhibition therapy of patients with artificial heart valves].
Orv Hetil. 1987 Feb 1;128(5):239-42.
10
Antithrombotic therapy in heart failure.
Expert Rev Cardiovasc Ther. 2006 May;4(3):277-8. doi: 10.1586/14779072.4.3.277.
Zotero 插件